The control of hypertension in pregnancy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000502:physiology; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004461:Eclampsia / Q000517:prevention & control; D005260:Female; D006706:Homeostasis; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008750:Methyldopa / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010920:Placenta / Q000098:blood supply; D011225:Pre-Eclampsia / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy* / Q000503:physiopathology; D011458:Prostaglandins E / Q000502:physiology; D012039:Regional Blood Flow; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D014704:Veratrum Alkaloids / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D011458:Prostaglandins E; D046948:Secologanin Tryptamine Alkaloids; D014704:Veratrum Alkaloids; D000804:Angiotensin II; D009599:Nitroprusside; D006830:Hydralazine; D008750:Methyldopa; D003981:Diazoxide